Literature DB >> 7559513

The assembly of laminin-5 subunits.

C Matsui1, C K Wang, C F Nelson, E A Bauer, W K Hoeffler.   

Abstract

Laminin-5 is a heterotrimer composed of alpha 3, beta 3, and gamma 2 chains, produced by keratinocytes and the human squamous cell carcinoma line (SCC-25), and is one of the candidate proteins for the genetic lesion in junctional epidermolysis bullosa. Two-dimensional SDS-polyacrylamide gel electrophoresis (first dimension, nonreducing conditions; second dimension, reducing conditions) revealed that the immunoprecipitated laminin-5 from a SCC-25 cell fraction consisted of alpha 3, beta 3, and gamma 2 monomers, a beta 3 gamma 2 heterodimer, and an alpha 3 beta 3 gamma 2 heterotrimer. The presence of the beta 3 gamma 2 heterodimer, but not heterodimers containing an alpha 3 chain and any of the other chains, was suggestive of assembly of laminin-5 proceeding from a beta 3 gamma 2 heterodimer to an alpha 3 beta 3 gamma 2 heterotrimer. We showed, by cotransfection experiments using full-length recombinant beta 3 and gamma 2 chains in a human cell line devoid of endogenous laminin-5, that stable heterodimers can be formed in the absence of alpha 3 chain expression. In the SCC-25 cell fraction, the alpha 3 monomer pool was the smallest of the monomers. Pulse-chase experiments using the cell fraction also indicated that the heterotrimer was assembled after a 10-min pulse and was nearly absent after a 24-h chase. These results are consistent with the synthesis of alpha 3 being limiting for heterotrimer assembly, with rapid association of the alpha 3 chain with beta 3 gamma 2 heterodimers to form complete heterotrimers. Treatment with tunicamycin reduced the size of each of the laminin-5 subunits, indicating that all chains are glycosylated, but that N-linked glycosylation is not necessary for chain assembly and secretion.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559513     DOI: 10.1074/jbc.270.40.23496

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Disruption of laminin beta2 chain production causes alterations in morphology and function in the CNS.

Authors:  R T Libby; C R Lavallee; G W Balkema; W J Brunken; D D Hunter
Journal:  J Neurosci       Date:  1999-11-01       Impact factor: 6.167

Review 2.  Gene therapy for a lethal genetic blistering disease: a status report.

Authors:  E A Bauer; G S Herron; M P Marinkovich; P A Khavari; A T Lane
Journal:  Trans Am Clin Climatol Assoc       Date:  1999

3.  IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa.

Authors:  J E Kuster; M H Guarnieri; J G Ault; L Flaherty; P J Swiatek
Journal:  Mamm Genome       Date:  1997-09       Impact factor: 2.957

4.  Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa.

Authors:  M Endo; P W Zoltick; A Radu; Q Jiang; J Qiujie; C Matsui; P M Marinkovich; J McGrath; K Tamai; J Uitto; A W Flake
Journal:  Gene Ther       Date:  2011-09-22       Impact factor: 5.250

5.  Distribution of basement membrane anchoring molecules in normal and transformed endometrium: altered expression of laminin gamma2 chain and collagen type XVII in endometrial adenocarcinomas.

Authors:  Marko Määttä; Sirpa Salo; Kaisa Tasanen; Ylermi Soini; Annikki Liakka; Leena Bruckner-Tuderman; Helena Autio-Harmainen
Journal:  J Mol Histol       Date:  2004-11       Impact factor: 2.611

6.  Overexpression of laminin-8 in human dermal microvascular endothelial cells promotes angiogenesis-related functions.

Authors:  Jie Li; Lisa Zhou; Hoang T Tran; Yi Chen; Ngon E Nguyen; Marvin A Karasek; M Peter Marinkovich
Journal:  J Invest Dermatol       Date:  2006-02       Impact factor: 8.551

7.  Integrin beta4 regulates migratory behavior of keratinocytes by determining laminin-332 organization.

Authors:  Bernd U Sehgal; Phillip J DeBiase; Sumio Matzno; Teng-Leong Chew; Jessica N Claiborne; Susan B Hopkinson; Alan Russell; M Peter Marinkovich; Jonathan C R Jones
Journal:  J Biol Chem       Date:  2006-09-14       Impact factor: 5.157

8.  Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro.

Authors:  Olga Igoucheva; Aislinn Kelly; Jouni Uitto; Vitali Alexeev
Journal:  J Invest Dermatol       Date:  2007-12-13       Impact factor: 8.551

9.  Topical application of laminin-332 to diabetic mouse wounds.

Authors:  Stephen R Sullivan; Robert A Underwood; Randall O Sigle; Yuko Fukano; Lara A Muffley; Marcia L Usui; Nicole S Gibran; Marcos A Antezana; William G Carter; John E Olerud
Journal:  J Dermatol Sci       Date:  2007-08-24       Impact factor: 4.563

10.  N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc.

Authors:  Yoshinobu Kariya; Rika Kato; Satsuki Itoh; Tomohiko Fukuda; Yukinao Shibukawa; Noriko Sanzen; Kiyotoshi Sekiguchi; Yoshinao Wada; Nana Kawasaki; Jianguo Gu
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.